Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) Inventory Average (2016 - 2026)

Syndax Pharmaceuticals (SNDX) has disclosed Inventory Average for 8 consecutive years, with $33.9 million as the latest value for Q1 2026.

  • For Q1 2026, Inventory Average rose 1245.96% year-over-year to $33.9 million; the TTM value through Mar 2026 reached $33.9 million, up 1245.96%, while the annual FY2025 figure was $16.6 million, N/A changed from the prior year.
  • Inventory Average hit $33.9 million in Q1 2026 for Syndax Pharmaceuticals, up from $28.9 million in the prior quarter.
  • Across five years, Inventory Average topped out at $33.9 million in Q1 2026 and bottomed at $2.5 million in Q1 2025.